Cleveland BioLabs (CBLI) volatility at historic lows

Cleveland BioLabs (Nasdaq: CBLI), a company developing a treatment for Acute Radiation Syndrome which can also be utilized as a radioprotectant in radiation oncology, is recently trading at $7.52. Overall option implied volatility of 58 is below its six-month average of 77 according to Track Data, suggesting decreasing price movement.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Uniti Group (UNIT) 3700 contracts of July 13 calls trade, share up 7%
• Lennar Corp. (LEN) call put ratio 1.8 calls to 1 put into quarter results
• Intel (INTC) call put ratio 1.2 calls to 1 put as share price up 6.7%